Skip to main content
Premium Trial:

Request an Annual Quote

Law Firms Investigating Monogram Over LabCorp Deal

NEW YORK (GenomeWeb News) – A few law firms have announced that they are investigating Monogram Biosciences' board of directors for possible breach of fiduciary duty following the firm's announcement yesterday that it has signed a definitive agreement to be acquired by Laboratory Corporation of America for around $107 million.

The law firms — Levi & Korsinsky; Brodsky & Smith; and Howard G. Smith — suggested that the price of the acquisition may not be fair to Monogram's shareholders.

The deal calls for LabCorp to pay Monogram's shareholders $4.55 per share, which is a significant premium over the firm's closing price of $1.68 on the Nasdaq the day before the transaction was announced. However, Monogram's shares traded at the equivalent of $7.20 in August 2008, adjusting for a 6-for-1 reverse stock split in November, according to the law firms.

Monogram and LabCorp hope to close the deal in the third quarter.

Monogram officials did not return a call seeking comment by the tiem this article was published.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.